Phizzle "Big 5" Launch: Connecting Workhorse GMP Data Sources to Digital Systems

The "Big 5" initiative, highlights how the Edge Maker platform now remotely operates five critical drug production instruments. This advancement creates the first production use case of a software-defined architecture in the pharmaceutical industry.

Michael Patrick, Chief Innovation Officer, demonstrates how to remotely control a particle counter from Atlanta while the device is in a Denver lab.